Shanghai Team Analyzes Mechanism That Enables Adult Cells To Behave Like Embryonic Stem Cells

Main Category: Stem Cell Research
Article Date: 08 Mar 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (2 votes)

Healthcare Prof:not yet rated


Agilent Technologies Inc. (NYSE:A) today announced its collaboration with a team from the Shanghai Institutes for Biological Sciences and Tongi University that has achieved new insight into how adult cells can be induced to act like embryonic stem cells (ESC), with the ability to form any type of tissue known as "pluripotency."

"The value of finding alternatives to embryonic stem cells would obviously be tremendous, and the ability to induce pluripotency in adult cells, discovered in 2006, is considered a breakthrough," said Jian Li of Agilent Technologies Shanghai, one of the article's coauthors. "Now we're gaining new understanding into how this pluripotency was actually induced."

Their findings were published in the journal"Cell Research," in an article titled "Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells" (Cell Research, 2008 18:1177-1189). The researchers observed a developmental signaling network of 16 signaling pathways, including nine that had not previously been assigned roles in maintaining or inducing pluripotency.

The study used Agilent chromatin immunoprecipitation-on-chip (ChIP-on-chip) and gene expression microarrays to study molecules known as "Yamanaka factors" and their roles in inducing pluripotency in mouse cells.

Agilent provided the microarray kits for this research under an Agilent grant issued in 2008. Microarrays are glass wafers containing large numbers of DNA probes used to analyze genomic activity. ChIP-on-chip microarrays are used to observe activity at "promoter regions" on the genome, where chemical events activate and deactivate various genes to control cellular functioning.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008. Information about Agilent is available on the Web at http://www.agilent.com.

Agilent Technologies

Article adapted by Medical News Today from original press release.
Visit our stem cell research section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Agilent Technologies. "Shanghai Team Analyzes Mechanism That Enables Adult Cells To Behave Like Embryonic Stem Cells." Medical News Today. MediLexicon, Intl., 8 Mar. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/141432.php>

APA
Agilent Technologies. (2009, March 8). "Shanghai Team Analyzes Mechanism That Enables Adult Cells To Behave Like Embryonic Stem Cells." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/141432.php.

Please note: If no author information is provided, the source is cited instead.


Stem Cell Research

What are Stem Cells?

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: embryonic stem cells and adult stem cells Read more...

Most Popular Articles



Follow Our Stem Cell Research News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Stem Cell Research Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »